Literature DB >> 14684221

The continuing challenge of intra-abdominal infection.

William G Cheadle1, David A Spain.   

Abstract

Intra-abdominal infection is common and frequently seen by the surgeon. Mortality is related to disease acuity and organ failure. This report, based on medical literature and personal experience, is a brief review of this subject, highlighting important historical milestones and recent advances in surgical and antibiotic therapy. Peritonitis remains a clinical challenge. Aggressive resuscitation, diagnostic imaging, and surgical treatment are the mainstays of appropriate therapy. Percutaneous drainage of intra-abdominal collections has increased over time and is particularly helpful in certain postoperative patients. Adjunctive antibiotic therapy against gram-negative aerobes and anaerobes should be limited to a 7- to 10-day course, except in selected patients, such as those with inadequate source controls.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14684221     DOI: 10.1016/j.amjsurg.2003.10.003

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  10 in total

1.  Differences in morbidity and mortality with percutaneous versus open surgical drainage of postoperative intra-abdominal infections: a review of 686 cases.

Authors:  Amani D Politano; Tjasa Hranjec; Laura H Rosenberger; Robert G Sawyer; Carlos A Tache Leon
Journal:  Am Surg       Date:  2011-07       Impact factor: 0.688

Review 2.  Management of peritonitis in the critically ill patient.

Authors:  Carlos A Ordoñez; Juan Carlos Puyana
Journal:  Surg Clin North Am       Date:  2006-12       Impact factor: 2.741

3.  Canadian practice guidelines for surgical intra-abdominal infections.

Authors:  Anthony W Chow; Gerald A Evans; Avery B Nathens; Chad G Ball; Glen Hansen; Godfrey Km Harding; Andrew W Kirkpatrick; Karl Weiss; George G Zhanel
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

Review 4.  Minimally Invasive Management of Complicated Diverticular Disease: Current Status and Review of Literature.

Authors:  Manu Kaushik; Jasneet Singh Bhullar; Sandiya Bindroo; Hemindermeet Singh; Vijay K Mittal
Journal:  Dig Dis Sci       Date:  2015-11-07       Impact factor: 3.199

5.  Persistent lymphopenia is an independent predictor of mortality in critically ill emergency general surgical patients.

Authors:  P E Vulliamy; Z B Perkins; K Brohi; J Manson
Journal:  Eur J Trauma Emerg Surg       Date:  2015-10-26       Impact factor: 3.693

6.  Regulation of virulence gene expression resulting from Streptococcus pneumoniae and nontypeable Haemophilus influenzae interactions in chronic disease.

Authors:  Emily K Cope; Natalia Goldstein-Daruech; Jennifer M Kofonow; Lanette Christensen; Bridget McDermott; Fernando Monroy; James N Palmer; Alexander G Chiu; Mark E Shirtliff; Noam A Cohen; Jeff G Leid
Journal:  PLoS One       Date:  2011-12-05       Impact factor: 3.240

7.  Distinct polymicrobial populations in a chronic foot ulcer with implications for diagnostics and anti-infective therapy.

Authors:  Can Imirzalioglu; Shneh Sethi; Christian Schneider; Torsten Hain; Trinad Chakraborty; Peter Mayser; Eugen Domann
Journal:  BMC Res Notes       Date:  2014-03-29

8.  Clinical Significance of Candida in an Intraoperative Peritoneal Specimen with Perforation Peritonitis: An Institutional Perspective.

Authors:  Jagannath Pramod; Chellappa Vijayakumar; Krishnamachari Srinivasan; Nanda Kishore Maroju; Nagarajan Raj Kumar; Gopal Balasubramaniyan
Journal:  Cureus       Date:  2018-03-05

Review 9.  Human polymicrobial infections.

Authors:  Kim A Brogden; Janet M Guthmiller; Christopher E Taylor
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

10.  A decision rule to aid selection of patients with abdominal sepsis requiring a relaparotomy.

Authors:  Jordy J S Kiewiet; Oddeke van Ruler; Marja A Boermeester; Johannes B Reitsma
Journal:  BMC Surg       Date:  2013-07-19       Impact factor: 2.102

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.